Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07149207
PHASE2

Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors

Sponsor: Medical University of South Carolina

View on ClinicalTrials.gov

Summary

This study is for adult patients with head and neck cancer who are at risk of recurrence. The purpose of this study is to evaluate whether the use of Indocyanine Green (ICG) dye allows for better identification of tumor tissue during surgical procedures. Participation will include standard of care visits along with administration of ICG dye and imaging during surgery. Participation in this study will last approximately 6 weeks.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2026-06-15

Completion Date

2026-12

Last Updated

2026-03-19

Healthy Volunteers

No

Interventions

DRUG

Indocyanine Green (ICG)

Dose: 5 mg/kg IV injection prior to surgery

Locations (1)

Medical University of South Carolina Hollings Cancer Center

Charleston, South Carolina, United States